SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-035555
Filing Date
2022-11-10
Accepted
2022-11-10 17:30:27
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5930
  Complete submission text file 0000899243-22-035555.txt   7560
Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Kewalramani Reshma (Reporting) CIK: 0001735944 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40097 | Film No.: 221378777

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)